Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases).
Gottenberg JE, Chaudier A, Allenbach Y, Mekinian A, Amoura Z, Cacoub P, Cornec D, Hachulla E, Quartier P, Melki I, Richez C, Seror R, Terrier B, Devauchelle-Pensec V, Henry J, Gatfosse M, Bouillet L, Gaigneux E, Andre V, Baulier G, Saunier A, Desmurs M, Poulet A, Ete M, Bienvenu B, Truchetet ME, Michaud M, Larroche C, Dellal A, Leurs A, Ottaviani S, Nielly H, Vial G, Jaussaud R, Rouvière B, Jeandel PY, Guffroy A, Korganow AS, Jouvray M, Meyer A, Chatelus E, Sordet C, Felten R, Sibilia J, Litim-Ahmed-Yahia S, Kleinmann JF, Mariette X. Gottenberg JE, et al. Among authors: dellal a. RMD Open. 2022 Nov;8(2):e002324. doi: 10.1136/rmdopen-2022-002324. RMD Open. 2022. PMID: 36319066 Free PMC article.
Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study.
Mirouse A, Seror R, Vicaut E, Mariette X, Dougados M, Fauchais AL, Deroux A, Dellal A, Costedoat-Chalumeau N, Denis G, Sellam J, Arlet JB, Lavigne C, Urbanski G, Fischer-Dumont D, Diallo A, Fain O, Mékinian A; Club Rhumatismes Inflammation and SNFMI. Mirouse A, et al. Among authors: dellal a. Autoimmun Rev. 2019 Jan;18(1):9-14. doi: 10.1016/j.autrev.2018.06.015. Epub 2018 Nov 5. Autoimmun Rev. 2019. PMID: 30408585 Free article.
Thrombotic microangiopathy associated with anti-neutrophil cytoplasmic antibody-associated vasculitis: a French nationwide retrospective case-control study and literature review.
Dellal A, Bige N, Hilliquin P, Boffa JJ, Rondeau E, Hatron PY, Deligny C, Bally S, Maury E, Veyradier A, Buob D, Fain O, Coppo P, Mekinian A. Dellal A, et al. Rheumatology (Oxford). 2019 Oct 1;58(10):1873-1875. doi: 10.1093/rheumatology/kez167. Rheumatology (Oxford). 2019. PMID: 31330026 Review. No abstract available.
Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves' Orbitopathy.
Bennedjaï A, Bouheraoua N, Gatfossé M, Dupasquier-Fediaevsky L, Errera MH, Tazartes M, Borderie V, Hennocq Q, Dellal A, Riviere S, Heron E, Fain O, Mekinian A. Bennedjaï A, et al. Among authors: dellal a. Ocul Immunol Inflamm. 2022 Feb 17;30(2):500-505. doi: 10.1080/09273948.2020.1808688. Epub 2020 Sep 23. Ocul Immunol Inflamm. 2022. PMID: 32965148
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. Felten R, et al. Among authors: dellal a. Ann Rheum Dis. 2021 Mar;80(3):329-338. doi: 10.1136/annrheumdis-2020-218467. Epub 2020 Nov 18. Ann Rheum Dis. 2021. PMID: 33208345 Clinical Trial.
Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study.
Cacciatore C, Belnou P, Thietart S, Desthieux C, Versini M, Abisror N, Ottaviani S, Cormier G, Deroux A, Dellal A, Belhomme N, Kermanac'H NS, Khafagy P, Michaud M, Lanot S, Carrat F, Fain O, Mékinian A. Cacciatore C, et al. Among authors: dellal a. Front Med (Lausanne). 2020 Dec 10;7:565420. doi: 10.3389/fmed.2020.565420. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33363181 Free PMC article.
TNF inhibitors for the management of inflammatory heart disease in spondyloarthritis: French multicentre case-series and literature review.
Tennenbaum J, Abisror N, Sellam J, Bigot A, Gourguechon C, Adedjouma A, Dellal A, Fain O, Mekinian A; Club Rhumatismes et Inflammations (CRI). Tennenbaum J, et al. Among authors: dellal a. Rheumatology (Oxford). 2021 Jul 1;60(7):e247-e249. doi: 10.1093/rheumatology/keab082. Rheumatology (Oxford). 2021. PMID: 33502470 Review. No abstract available.
Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study.
Larosa M, Le Guern V, Guettrot-Imbert G, Morel N, Abisror N, Morati-Hafsaoui C, Orquevaux P, Diot E, Doria A, Sarrot-Reynauld F, Limal N, Queyrel V, Souchaud-Debouverie O, Sailler L, Le Besnerais M, Goulenok T, Molto A, Pannier-Metzger E, Sentilhes L, Mouthon L, Lazaro E, Costedoat-Chalumeau N; GR2 Group. Larosa M, et al. Rheumatology (Oxford). 2022 Aug 30;61(9):3657-3666. doi: 10.1093/rheumatology/keab943. Rheumatology (Oxford). 2022. PMID: 35015828 Free PMC article.
95 results